delete

Recent Study Reveals Interesting Informa...

Patients who are treated with recurrent glioblastoma multiforme (GBM) have a potential vaccine that may improve survival time.  This experimental vaccine is made from the patient’s own resected tumor tissue.  Over the past few years, this procedure has helped some people to extend their lives longer than those who are diagnosed with GBM and are treated with standard care. A study from the journal Neuro-Oncology known as the “phase 2 trial” took 41 patients with GBM-related tumors during the years of 2007 to 2011.  Each adult received an average of six doses from a vaccine...